Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUATUOR: 4-Day vs 7-Day Antiretroviral Therapy in HIV-1
NCT03256422Phase 3Completed
- Sponsor
- ANRS
- Start
- Sep 2017
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by ANRS. Primary endpoint: Proportion of patients with therapeutic success at 48 weeks. Started Sep 2017; status: completed.
02
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03256422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256422.